Cargando…
New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy
Chemotherapeutics drugs play a pivotal role in the treatment of cancer. However, many issues generate by chemotherapy drugs, including unfavorable harm to healthy cells and multidrug resistance (MDR), persist and have a negative impact on therapeutic outcomes. When compared to monotherapy, combinati...
Autores principales: | Kumar, Krishan, Rani, Varsha, Mishra, Mohini, Chawla, Ruchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108887/ https://www.ncbi.nlm.nih.gov/pubmed/35586474 http://dx.doi.org/10.1016/j.crphar.2022.100103 |
Ejemplares similares
-
New paradigms on siRNA local application
por: Pan, Meng, et al.
Publicado: (2015) -
siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010) -
Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy
por: Ahmed, Muneeb, et al.
Publicado: (2015) -
Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers
por: Mendes, Livia P., et al.
Publicado: (2019) -
Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)